The Planning Shop International has been acquired by Adelphi Worldwide
September 2014 — The founding shareholders of The Planning Shop International (TPSI) have sold the company to Adelphi Worldwide, part of the Omnicom Group. Financial details have not been disclosed.
TPSI is a specialist pharmaceutical brand strategy agency. The company provides a unique consumer-based insight into every step of the product life cycle.
Adelphi Worldwide, part of the Omnicom Group, is engaged in pharmaceutical consultancy and service provision. Adelphi’s offer spans the lifecycle of pharmaceutical development, with comprehensive services in strategic product development consultancy, health economics and outcomes research, real world disease understanding, marketing research, medical communications and post-meeting brand support services.
Our role in the transaction
Oaklins Cavendish, based in the UK, advised the seller in this transaction.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more